Results from KEYNOTE-B99: Phase 2 Study of First-Line (1L) Pembrolizumab (pembro) Plus Investigational Agents and Chemotherapy (chemo) for Extensive-Stage Small-Cell Lung Cancer (ES-SCLC)

Delvys Rodriguez-Abreu, Maximillian Hochmair, Byoung Chul Cho,Tibor Csoszi, Talia Shentzer Kutiel, Veronika Mueller, Myung-Ju Ahn, Dariusz Kowalski,Michele Maio,Vladimir Moiseyenko,Alejandro Navarro, Jianxin Niu, Andrea S. Fung, Carolin Lips, Heng Zhou, Bin Zhao, Humberto Lara-Guerra, Nir Peled

CANCER RESEARCH（2024）

引用 0|浏览1

暂无评分

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要